EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smokers

Sponsor
Southern Illinois University Carbondale (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02129387
Collaborator
(none)
115
1
92
1.3

Study Details

Study Description

Brief Summary

The purpose of the proposal is to identify new predictors of smoking progression in young light smokers (YLS: 18-25 years & cpd < 5) using an 18-month longitudinal design and to relate these predictors of progression to the genetic profile most highly associated with smoking progression. A number of novel predictors will be assessed in 128 YLS. Predictors will include individual differences (IDs) in EEG, reward sensitivity, attentional performance, and mood during abstinence and in response to standardized and to self-selected acute nicotine doses (ANIC), as well as genetically influenced affective traits, and smoking history. The associations of a compelling genetic functional variant polymorphism, rs16969968, in the alpha5 nicotinic receptor subunit will also be related to smoking progression and the novel predictors. The study is expected to provide insights into IDs in mechanisms and predictors that contribute to smoking trajectories in YLS and thereby lead to targeted pharmacotherapy and behavioral interventions for at-risk YLS.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The purpose of the proposal is to identify new biobehavioral endophenotypes that predict smoking progression in young light smokers (YLS: 18-25 years & cpd < 5) using an 18-month longitudinal design and to relate these endophenotypes and progression to the genetic profile most highly associated with smoking progression. A number of novel predictors will be assessed in 128 YLS. Predictors will include individual differences (IDs) in EEG, reward sensitivity, attentional performance, and mood during abstinence and in response to standardized and to self-selected acute nicotine doses (ANIC), as well as genetically influenced affective traits, and smoking history. The associations of a compelling genetic functional variant polymorphism, rs16969968, in the alpha5 nicotinic receptor subunit will also be related to smoking progression and the novel predictors. The study is expected to provide insights into IDs in mechanisms and endophenotypes that contribute to smoking trajectories in YLS and thereby lead to targeted pharmacotherapy and behavioral interventions for at-risk YLS.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    115 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smokers
    Actual Study Start Date :
    Apr 1, 2014
    Anticipated Primary Completion Date :
    Oct 31, 2021
    Anticipated Study Completion Date :
    Nov 30, 2021

    Outcome Measures

    Primary Outcome Measures

    1. change in smoking and salivary cotinine concentration [18 months]

      Change in smoking and salivary cotinine concentration from baseline to 18 months will be assessed at 3 month intervals-- 3, 6, 9, 12, 15, and 18 months after initial assessments.

    Secondary Outcome Measures

    1. reason for change in smoke rate [18 months after initial assessment]

      Self-reported reasons for changing smoking or for continuing to smoke at the same rate will be assessed a 3-month intervals until 18 months after baseline assessment.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 25 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • smokers of 3 to 30 cigarettes per week for past 6 months
    Exclusion Criteria:
    • Smoking fewer than 3 or more than 30 tobacco cigarettes per week

    • Never smoked more than 30 cigarettes per week

    • Psychoactive drug use other than caffeine or occasional marijuana

    • Current serious psychiatric diagnosis (e.g., major depressive disorder)

    • Recent drug dependence

    • Left-handed

    • Color blind

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Southern Illinois University Carbondale Department of Psychology Carbondale Illinois United States 62901-6502

    Sponsors and Collaborators

    • Southern Illinois University Carbondale

    Investigators

    • Principal Investigator: David G Gilbert, PhD, Southern Illinois University Carbondale

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Southern Illinois University Carbondale
    ClinicalTrials.gov Identifier:
    NCT02129387
    Other Study ID Numbers:
    • 1R01DA036032-01
    First Posted:
    May 2, 2014
    Last Update Posted:
    Mar 23, 2021
    Last Verified:
    Mar 1, 2021
    Keywords provided by Southern Illinois University Carbondale
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 23, 2021